Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Harmony Biosciences Holdings
HRMYCurrent price
38.34 USD
-0.47 USD (-1.21%)
Last closed
38.81 USD
Company
www.harmonybiosciences.com
ISIN
US4131971040
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 211 438 080 USD
Yield for 12 month
+4.24 %
1Y
3Y
5Y
10Y
15Y
HRMY
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania. Address: 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
43.29 USDP/E ratio
19.9538Dividend Yield
–Current Year
+582 022 000 USD
Last Year
+437 855 000 USD
Current Quarter
+172 814 000 USD
Last Quarter
+154 615 000 USD
Current Year
+460 786 000 USD
Last Year
+354 374 000 USD
Current Quarter
+134 709 000 USD
Last Quarter
+121 170 000 USD
Key Figures HRMY
1 year
3 years
5 years
10 years
EBITDA
202 500 992 USD
Operating Margin TTM
PE Ratio
19.9538
Return On Assets TTM
13.75 %
PEG Ratio
–
Return On Equity TTM
22.47 %
Wall Street Target Price
43.29 USD
Revenue TTM
656 108 992 USD
Book Value
9.48 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
28.8 %
Dividend Yield
–
Gross Profit TTM
354 374 000 USD
Earnings per share
1.95 USD
Diluted Eps TTM
1.95 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-64.3 %
Profit Margin
17.53 %
Dividend Analytics HRMY
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HRMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation HRMY
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
19.9538
Forward PE
9.7752
Enterprise Value Revenue
3.1259
Price Sales TTM
3.3705
Enterprise Value EBITDA
9.7593
Price Book MRQ
4.106
Financials HRMY
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators HRMY
For 52 weeks
18.61 USD
39.73 USD
50 Day MA
34.6 USD
Shares Short Prior Month
8 726 295
200 Day MA
32.04 USD
Short Ratio
27.79
Shares Short
8 755 100
Short Percent
68.77 %
BeatStart